Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Dantrolene

2

V.b Eosinophilic pleural effusion

1
Last update : 20/01/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Iatrogenic eosinophilic pleural effusion.
European respiratory review : an official journal of the European Respiratory Society 2011 Jun;20;118-20 2011 Jun
Dantrolene and pleural effusion: case report and review of literature.
Spinal cord 2004 May;42;317-20 2004 May
Eosinophilic pleural effusion due to dantrolene: resolution with steroid therapy.
Southern medical journal 2001 May;94;502-4 2001 May
[Dantrolene-induced pleurisy: a case report].
Revue de pneumologie clinique 2000 Sep;56;261-3 2000 Sep
Pleural effusion associated with chronic dantrolene administration.
The Annals of pharmacotherapy 1994 May;28;587-9 1994 May
Pneumonitis, pleural effusion and pericarditis following treatment with dantrolene.
Journal of neurology, neurosurgery, and psychiatry 1984 May;47;553-4 1984 May
Pleuropericardial reaction to treatment with dantrolene.
JAMA 1979 Dec 21;242;2772-4 1979 Dec 21

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies